Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Borie, B. Crestani, P. Dieude, H. Nunes, Y. Allanore, C. Kannengiesser, P. Airo, M. Matucci-Cerinic, B. Wallaert, D. Israel-Biet, J. Cadranel, V. Cottin, D. Valeyre, B. Grandchamp (Paris, Bobigny, Lyon, Lille, France; Brescia, Italy). The functional MUC5B rs35705950 promoter polymorphism is associated with IPF but not with systemic sclerosis related interstitial lung disease. Eur Respir J 2012; 40: Suppl. 56, 3145

Member's Comments

No comment yet.

Related content which might interest you: The MUC5B promoter polymorphism is associated with specific interstitial lung abnormality subtypes Source: Eur Respir J, 50 (3) 1700537; 10.1183/13993003.00537-2017 Year: 2017 The MUC5B promoter risk allele for idiopathic pulmonary fibrosis predisposes to asbestosis Source: Eur Respir J, 55 (4) 1902361; 10.1183/13993003.02361-2019 Year: 2020 Correlation of IL-1 alpha and IL-4 promotor region gene polymorphisms and clinical parameters in idiopathic pulmonary fibrosis Source: Annual Congress 2006 - Systemic diseases, environmental and genetic factors in interstitial lung disease Year: 2006 IL-1α gene polymorphism in pulmonary sarcoidosis in relation to disease severity Source: Eur Respir J 2002; 20: Suppl. 38, 172s Year: 2002 CARD15/NOD2 polymorphisms are associated with severe pulmonary sarcoidosis Source: Eur Respir J 2010; 35: 324-330 Year: 2010 Angiotensinogen gene G-6A polymorphism influences idiopathic pulmonary fibrosis disease progression Source: Eur Respir J 2008; 32: 1004-1008 Year: 2008 Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients Source: Eur Respir J 2008; 32: 372-378 Year: 2008 The functional polymorphisms in the IL-18 gene promoter is associated with the pathogenesis of sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 180s Year: 2003 To correlate of the NOS1 C/T polymorphism with the activity of proteases and antiproteases in the serum and sputum in chronic obstructive pulmonary disease patients Source: Eur Respir J 2006; 28: Suppl. 50, 585s Year: 2006 MUC5B is expressed by bronchoalveolar epithelia and is associated with ER stress in idiopathic pulmonary fibrosis and rheumatoid arthritis associated interstitial lung disease Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias Year: 2018 A BTNL2 gene variant confers to sarcoidosis susceptibility by an increased risk towards the chronic form of the disease Source: Eur Respir J 2006; 28: Suppl. 50, 148s Year: 2006 VNTR polymorphism NOS3 gene among chronic obstructive pulmonary disease patients Source: Eur Respir J 2003; 22: Suppl. 45, 392s Year: 2003 IGFBP-2: a new pathway in systemic sclerosis associated interstitial lung disease Source: International Congress 2019 – Connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis: what’s new? Year: 2019 MUC5B genotype affects survival of patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019 Effect of MUC5B gene polymorphism on survival in a Lebanese population of patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 IL-13 polymorphism: predisposition towards COPD and asbestos-induced diseases Source: Eur Respir J 2001; 18: Suppl. 33, 535s Year: 2001 The 15q24/25 susceptibility variant for lung cancer and COPD is associated with emphysema Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010 Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis Source: Eur Respir J 2011; 38: 1355-1360 Year: 2011 TNF gene polymorphisms and asthma development in cystic fibrosis patients Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies Year: 2010 IL8 as a marker of severity of disease progression in patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2007; 30: Suppl. 51, 373s Year: 2007